{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:57:06Z","timestamp":1649087826765},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,4,6]],"date-time":"2007-04-06T00:00:00Z","timestamp":1175817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,28]]},"DOI":"10.1007\/s10067-007-0599-9","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T04:37:41Z","timestamp":1175747861000},"page":"1981-1983","source":"Crossref","is-referenced-by-count":3,"title":["Microscopic polyangiitis and myasthenia gravis: the battle of Occam and Hickam"],"prefix":"10.1007","volume":"26","author":[{"given":"Michael V.","family":"Holmes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,6]]},"reference":[{"issue":"3","key":"599_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","volume":"42","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42(3):421\u2013430","journal-title":"Arthritis Rheum"},{"key":"599_CR2","unstructured":"Clinical features of primary ANCA-associated vasculitis. In: Isenberg D, Maddison P, Woo P et al (eds) (2004) Oxford textbook of rheumatology, 3rd edn. Oxford University Press, Oxford, pp 943\u2013957"},{"issue":"5","key":"599_CR3","first-page":"291","volume":"87","author":"A Davenport","year":"1994","unstructured":"Davenport A, Lock RJ, Wallington TB, Feest TG (1994) Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. Q J Med 87(5):291\u2013299, (May)","journal-title":"Q J Med"},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1212\/WNL.10.11.1007","volume":"10","author":"JG Millichap","year":"1960","unstructured":"Millichap JG, Dodge PR (1960) Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence: a study of 51 patients. Neurology 10:1007\u20131014","journal-title":"Neurology"},{"issue":"12","key":"599_CR5","first-page":"CR684","volume":"10","author":"A Qureshi","year":"2004","unstructured":"Qureshi A, Choundry M, Mohammad Y et al (2004) Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 10(12):CR684\u2013CR689","journal-title":"Med Sci Monit"},{"issue":"7","key":"599_CR6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00003246-199707000-00027","volume":"25","author":"J Berrouschot","year":"1997","unstructured":"Berrouschot J, Baumann I, Kalischewski P et al (1997) Therapy of myasthenic crisis. Crit Care Med 25(7):1228\u20131235","journal-title":"Crit Care Med"},{"issue":"1","key":"599_CR7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1749-6632.1966.tb45497.x","volume":"135","author":"B Castleman","year":"1966","unstructured":"Castleman B (1966) The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci 135(1):496\u2013505","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"599_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-1331.2003.00678.x","volume":"10","author":"F Romi","year":"2003","unstructured":"Romi F, Gilhus NE, Varhaug JE et al (2003) Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10(6):701\u2013706","journal-title":"Eur J Neurol"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.1993.tb22869.x","volume":"681","author":"HK Muller-Hermelink","year":"1993","unstructured":"Muller-Hermelink HK, Marx A, Geuder K et al (1993) The pathological basis of thymoma-associated myasthenia gravis. Ann N Y Acad Sci 681:56\u201365","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"599_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","volume":"128","author":"F Romi","year":"2002","unstructured":"Romi F, Bo L, Skeie GO et al (2002) Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128(1\u20132):82\u201389","journal-title":"J Neuroimmunol"},{"issue":"5","key":"599_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.16.5.431","volume":"16","author":"VP Perlo","year":"1966","unstructured":"Perlo VP, Poskanzer DC, Schwab RS (1966) Myasthenia gravis: evaluation of treatment in 1,355 patients. Neurology 16(5):431\u2013439","journal-title":"Neurology"},{"issue":"2","key":"599_CR12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/WNL.31.2.220","volume":"31","author":"AD Roses","year":"1981","unstructured":"Roses AD, Olanow CW, McAdams MW et al (1981) No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology 31(2):220\u2013224","journal-title":"Neurology"},{"key":"599_CR13","volume-title":"Oxford textbook of medicine","author":"DA Warrell","year":"2004","unstructured":"Warrell DA (2004) Disorders of the neuromuscular junction. In: Warrell DA, Cox TM, Firth JD, Benz EJ (eds) Oxford textbook of medicine, 4th edn. Oxford University Press, Oxford, (Section 24.42)","edition":"4"},{"issue":"4","key":"599_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.44.4.245","volume":"44","author":"T Swaak","year":"1985","unstructured":"Swaak T, Smeenk R (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 44(4):245\u2013251, (Apr)","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"599_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0090-1229(91)90086-P","volume":"59","author":"EJ Borg ter","year":"1991","unstructured":"ter Borg EJ, Horst G, Hummel E et al (1991) Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation. Clin Immunol Immunopathol 59(1):117\u2013128, Apr","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0599-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0599-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:07Z","timestamp":1559105467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0599-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,6]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,9,28]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0599-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,6]]}}}